MedTrace Logo

The Rule-Out Acute Myocardial Infarction Using Aritifical Intelligence Electrocardiogram (ROMIAE) 2 Trial

NCT07027891 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4670

Last updated 2025-12-24

No results posted yet for this study

Summary

This study is to see whether the AI ECG assisted protocol is as safe and efficacious as conventional protocol in early triage of suspected myocardial infarction.

Conditions

  • Myocardial Infarction (MI)
  • Chest Pain Rule Out Myocardial Infarction

Interventions

DEVICE

AI-ECG

The patients in AI-ECG group would be managed with the information of the myocardial infarction risk score in AI-ECG in addition to the usual care.

Sponsors & Collaborators

  • CHA University

    lead OTHER

Principal Investigators

  • KYUSEOK Kim, MD, PhD · CHA University

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-01
Primary Completion
2027-12-30
Completion
2028-02-28

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07027891 on ClinicalTrials.gov